Shareholding disclosure

HBM BioCapital USD and HBM BioCapital EUR

Declared position

4.92%

Threshold

Crossed upwards

Timeline

Published

29.05.2009

Transaction

20.05.2009

Transfer date

20.05.2009

Voting rights breakdown

Voting rights acquired4.92%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TA95S00033

Beneficial owner

HBM BioCapital USD and HBM BioCapital EUR

Declared address

HBM BioCapital (USD) and HBM BioCapital (EUR)

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

HBM BioCapital USD and HBM BioCapital EUR

Newron Pharmaceuticals S.p.A.29.05.2009TA95S00033

Disclosure summary

HBM BioCapital USD and HBM BioCapital EUR disclosed a holding in Newron Pharmaceuticals S.p.A. on the acquisition side, published by SIX Exchange Regulation on 29.05.2009, at 4.92% of voting rights. Notice category: Single shareholder.

Disclosed position

4.92%

Voting rights acquired

Voting rights acquired4.92%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

HBM BioCapital USD and HBM BioCapital EUR disclosed a holding in Newron Pharmaceuticals S.p.A., published on 29.05.2009.

Publication date29.05.2009

Transaction date20.05.2009

Transfer date20.05.2009

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerHBM BioCapital USD and HBM BioCapital EUR

Declared addressHBM BioCapital (USD) and HBM BioCapital (EUR)

CategorySingle shareholder

Voting rights acquired4.92%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTA95S00033

Source: SIX Exchange Regulation · Publication date: 29.05.2009

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open